Avalo Therapeutics (AVTX) had the highest return in March 2024 by a US stock with a market cap of $150M+, returning 397.7%.

ASSET	MONTH	% RETURN
Avalo Therapeutics (AVTX)	March 2024	397.71%
Airship AI (AISP)	March 2024	327.92%
Destiny Tech100 (DXYZ)	March 2024	203.03%
Cardiff Oncology (CRDF)	March 2024	167%
Canopy Growth (CGC)	March 2024	159.94%
Mesoblast (MESO)	March 2024	151.76%
Sonida Senior Living (SNDA)	March 2024	145.37%
KULR Technology (KULR)	March 2024	137.5%
Veritone (VERI)	March 2024	129.69%
Curiositystream (CURI)	March 2024	122.9%
Astera Labs, Inc Common Stock (ALAB)	March 2024	106.08%
Niagen Bioscience (NAGE)	March 2024	105.92%
Roboai (AIIO)	March 2024	103.22%
Nuvation Bio (NUVB)	March 2024	95.7%
Apogee Therapeutics, Inc Common Stock (APGE)	March 2024	90.67%
Elicio Therapeutics (ELTX)	March 2024	89.53%
Frequency Therapeutics (KRRO)	March 2024	88.68%
Ehang (EH)	March 2024	88.37%
Arq (ARQ)	March 2024	87.83%
Sezzle (SEZL)	March 2024	87.71%
WM Technology (MAPSW)	March 2024	85.19%
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW)	March 2024	85.05%
Atossa Genetics (ATOS)	March 2024	83.3%
TheRealReal (REAL)	March 2024	81.02%
Root (ROOT)	March 2024	77.76%